Post Exposure Prophylaxis with Hydroxychloroquine (HCQ) for the Prevention of COVID-19, a Myth or a Reality? The PEP-CQ Study

DOI record: { "DOI": "10.1016/j.ijantimicag.2020.106224", "ISSN": [ "0924-8579" ], "URL": "http://dx.doi.org/10.1016/j.ijantimicag.2020.106224", "alternative-id": [ "S0924857920304350" ], "article-number": "106224", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Journal of Antimicrobial Agents" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ijantimicag.2020.106224" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Dhibar", "given": "Deba Prasad", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-4507-2468", "affiliation": [], "authenticated-orcid": false, "family": "Arora", "given": "Navneet", "sequence": "additional" }, { "affiliation": [], "family": "Kakkar", "given": "Arpit", "sequence": "additional" }, { "affiliation": [], "family": "Singla", "given": "Neeraj", "sequence": "additional" }, { "affiliation": [], "family": "Mohindra", "given": "Ritin", "sequence": "additional" }, { "affiliation": [], "family": "Suri", "given": "Vikas", "sequence": "additional" }, { "affiliation": [], "family": "Bhalla", "given": "Ashish", "sequence": "additional" }, { "affiliation": [], "family": "Sharma", "given": "Navneet", "sequence": "additional" }, { "affiliation": [], "family": "Singh", "given": "Mini P.", "sequence": "additional" }, { "affiliation": [], "family": "Prakash", "given": "Ajay", "sequence": "additional" }, { "affiliation": [], "family": "PVM", "given": "Lakshmi", "sequence": "additional" }, { "affiliation": [], "family": "Medhi", "given": "Bikash", "sequence": "additional" } ], "container-title": "International Journal of Antimicrobial Agents", "container-title-short": "International Journal of Antimicrobial Agents", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 11, 6 ] ], "date-time": "2020-11-06T07:19:18Z", "timestamp": 1604647158000 }, "deposited": { "date-parts": [ [ 2022, 4, 2 ] ], "date-time": "2022-04-02T00:31:35Z", "timestamp": 1648859495000 }, "indexed": { "date-parts": [ [ 2024, 2, 22 ] ], "date-time": "2024-02-22T21:04:37Z", "timestamp": 1708635877120 }, "is-referenced-by-count": 13, "issue": "6", "issued": { "date-parts": [ [ 2020, 12 ] ] }, "journal-issue": { "issue": "6", "published-print": { "date-parts": [ [ 2020, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 12, 1 ] ], "date-time": "2020-12-01T00:00:00Z", "timestamp": 1606780800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0924857920304350?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0924857920304350?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "106224", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 12 ] ] }, "published-print": { "date-parts": [ [ 2020, 12 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.ijantimicag.2020.106224_bib0001", "series-title": "WHO coronavirus disease (COVID-19) dashboard", "year": "2020" }, { "key": "10.1016/j.ijantimicag.2020.106224_bib0002", "series-title": "COVID-19 dashboard", "year": "2020" }, { "DOI": "10.1056/NEJMoa2002032", "article-title": "China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China", "author": "Guan", "doi-asserted-by": "crossref", "first-page": "1708", "journal-title": "N Engl J Med", "key": "10.1016/j.ijantimicag.2020.106224_bib0003", "volume": "382", "year": "2020" }, { "DOI": "10.1056/NEJMe2005477", "article-title": "Covid-19—the search for effective therapy", "author": "Baden", "doi-asserted-by": "crossref", "first-page": "1851", "journal-title": "N Engl J Med", "key": "10.1016/j.ijantimicag.2020.106224_bib0004", "volume": "382", "year": "2020" }, { "DOI": "10.4103/ijp.IJP_119_20", "article-title": "Therapeutic options for the treatment of 2019-novel coronavirus: an evidence-based approach", "author": "Sarma", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Indian J Pharmacol", "key": "10.1016/j.ijantimicag.2020.106224_bib0005", "volume": "52", "year": "2020" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "269", "journal-title": "Cell Res", "key": "10.1016/j.ijantimicag.2020.106224_bib0006", "volume": "30", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial", "author": "Gautret", "doi-asserted-by": "crossref", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijantimicag.2020.106224_bib0007", "volume": "56", "year": "2020" }, { "DOI": "10.1021/jm0601856", "article-title": "Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities", "author": "Biot", "doi-asserted-by": "crossref", "first-page": "2845", "journal-title": "J Med Chem", "key": "10.1016/j.ijantimicag.2020.106224_bib0008", "volume": "49", "year": "2006" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "first-page": "732", "journal-title": "Clin Infect Dis", "key": "10.1016/j.ijantimicag.2020.106224_bib0009", "volume": "71", "year": "2020" }, { "DOI": "10.1016/j.ophtha.2016.01.058", "article-title": "American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)", "author": "Marmor", "doi-asserted-by": "crossref", "first-page": "1386", "journal-title": "Ophthalmology", "key": "10.1016/j.ijantimicag.2020.106224_bib0010", "volume": "123", "year": "2016" }, { "key": "10.1016/j.ijantimicag.2020.106224_bib0011", "series-title": "Advisory on the use of hydroxy-chloroquine as prophylaxis for SARS-CoV-2 infection", "year": "2020" }, { "DOI": "10.1056/NEJMoa2016638", "article-title": "A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19", "author": "Boulware", "doi-asserted-by": "crossref", "first-page": "517", "journal-title": "N Engl J Med", "key": "10.1016/j.ijantimicag.2020.106224_bib0012", "volume": "383", "year": "2020" }, { "DOI": "10.1002/jmv.25898", "article-title": "Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: a systematic review and meta-analysis", "author": "Sarma", "doi-asserted-by": "crossref", "first-page": "776", "journal-title": "J Med Virol", "key": "10.1016/j.ijantimicag.2020.106224_bib0013", "volume": "92", "year": "2020" }, { "key": "10.1016/j.ijantimicag.2020.106224_bib0014", "series-title": "‘Solidarity’ clinical trial for COVID-19 treatments", "year": "2020" }, { "DOI": "10.1136/bmj.m1375", "article-title": "Covid-19: four fifths of cases are asymptomatic, China figures indicate", "author": "Day", "doi-asserted-by": "crossref", "first-page": "m1375", "journal-title": "BMJ", "key": "10.1016/j.ijantimicag.2020.106224_bib0015", "volume": "369", "year": "2020" }, { "article-title": "Detection of SARS-CoV-2 in different types of clinical specimens", "author": "Wang", "first-page": "1843", "journal-title": "JAMA", "key": "10.1016/j.ijantimicag.2020.106224_bib0016", "volume": "323", "year": "2020" }, { "DOI": "10.4103/ijmr.IJMR_2234_20", "article-title": "Healthcare workers & SARS-CoV-2 infection in India: a case–control investigation in the time of COVID-19", "author": "Chatterjee", "doi-asserted-by": "crossref", "first-page": "459", "journal-title": "Indian J Med Res", "key": "10.1016/j.ijantimicag.2020.106224_bib0017", "volume": "151", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101738", "article-title": "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France", "author": "Million", "doi-asserted-by": "crossref", "journal-title": "Travel Med Infect Dis", "key": "10.1016/j.ijantimicag.2020.106224_bib0018", "volume": "35", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.106144", "article-title": "Belgian Collaborative Group on COVID-19 Hospital Surveillance. Low-dose hydroxychloroquine therapy and mortality in hospitalized patients with COVID-19: a nationwide observational study of 8075 participants", "author": "Catteau", "doi-asserted-by": "crossref", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijantimicag.2020.106224_bib0019", "volume": "56", "year": "2020" }, { "article-title": "Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials", "author": "Anglemyer", "issue": "4", "journal-title": "Cochrane Database Syst Rev", "key": "10.1016/j.ijantimicag.2020.106224_bib0020", "year": "2014" } ], "reference-count": 20, "references-count": 20, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924857920304350" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Pharmacology (medical)", "Infectious Diseases", "Microbiology (medical)", "General Medicine" ], "subtitle": [], "title": "Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "56" }